Epidemiology and Public Health Posters
301 - UNDERSTANDING THE RELATIONSHIP BETWEEN CHILDHOOD FOSTER CARE AND HIV-VULNERABILITY AMONG ABORIGINAL YOUTH THAT USE INJECTION AND NON-INJECTION DRUGS
302 - EVALUATING NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY
303 - USE OF STERILE DRUG PREPARATION AND INJECTION MATERIALS DEPENDS ON DRUG OF CHOICE AMONG INJECTION DRUG USERS IN MONTREAL
304 - UNPROTECTED ANAL INTERCOURSE WITH PARTNERS HAVING UNKNOWN HIV SEROSTATUS IN RELATION TO DISCLOSURE-RELATED SOCIAL NORMS AMONG GAY MEN
305 - HIV REPORTABILITY USING NON NOMINAL IDENTIFIERS: DOES IT WORK?
306 - DOES MAKING HIV A REPORTABLE DISEASE SERVE AS A DISINCENTIVE TO HIV TESTING?
307 - THE IMPACT OF HIV REPORTABILITY ON PUBLIC HEALTH NURSING IN BRITISH COLUMBIA
308 - EVALUATING PHYSICIANS' EXPERIENCE WITH HIV REPORTABILITY
309 - GBV-C COINFECTION IN THAI HIV-INFECTED PREGNANT WOMEN
310 - HIV AND SEXUALLY TRANSMITTED INFECTION (STI) PREVENTION AND SCREENING IN MASSAGE PARLOURS, A COLLABORATION: NURSES AND PEERS
311 - HIV/STD AND PAP SCREENING IN COMMUNITY TARGETED AT VULNERABLE WOMEN IN VANCOUVER'S DOWNTOWN EASTSIDE (DTES)
312 - THE MULTIDIMENSIONAL QUALITY OF LIFE QUESTIONNAIRE FOR PERSONS WITH HIV (MQoL-HIV): MEASURING THE QUALITY OF LIFE OF PERSONS LIVING WITH HIV (PWHIV)(THE MAYA STUDY GROUP)
313 - FERTILITY INTENTIONS AND REPRODUCTIVE HEALTH CONCERNS IN ABORIGINAL HIV POSITIVE WOMEN IN BRITISH COLUMBIA
314 - SEXUAL HEALTH CONCERNS AND CONTRACEPTIVE CHOICES OF HIV POSITIVE WOMEN OVER THE AGE OF 45
315 - CONTRACEPTIVE DECISIONS OF SEXUALLY ACTIVE HIV POSITIVE WOMEN OF REPRODUCTIVE AGE
316 - AN ON-LINE HIV/STI INFORMATION AND REFERRAL SERVICE: A PILOT PROJECT
317 - TRENDS IN HIV PREVALENCE AND RISK BEHAVIOURS AMONG TORONTO INJECTION DRUG USERS SINCE 1992
318 - HUMAN RIGHTS AND PUBLIC HEALTH ETHICS IN SYNERGY: IMPLICATIONS FOR HIV/AIDS
319 - THE TORONTO EAST AFRICAN STUDY (EAST): IMPROVING VALIDITY OF REPORTED HIV RELATED BEHAVIOUR THROUGH COLLABORATION WITH KEY COMMUNITY MEMBERS
320 - HIV ANTIBODY TESTING AMONG SERONEGATIVE GAY MEN IN QUÉBEC CITY
321 - ENABLING FACTORS AND OBSTACLES IN PRIMARY HEALTH CARE AND EMERGENCY SERVICE UTILIZATION BY INJECTION DRUG USERS
322 - PREDICTORS OF UNSCHEDULED TREATMENT INTERRUPTION IN PATIENTS ON ANTIRETROVIRAL THERAPY
323 - DISTRIBUTION OF HIV SUB-TYPES AMONG PERSONS NEWLY DIAGNOSED WITH HIV IN ONTARIO, 2003-04
324 - CONTEXTUALIZING STI/HIV/AIDS AND BEHAVIOUR CHANGE IN RURAL KENYA
325 - HEALTH RELATED HARMS OF CRACK COCAINE SMOKING
326 - FACTORS ASSOCIATED WITH EARLY ADOLESCENT INITIATION INTO INJECTION DRUG USE: IMPLICATIONS FOR INJECTION DRUG USE INTERVENTION PROGRAMS
327 - ELEVATED RATES OF HIV INFECTION AMONG YOUNG ABORIGINAL INJECTION DRUG USERS IN A CANADIAN SETTING
328 - FACTORS ASSOCIATED WITH WILLINGNESS TO PARTICIPATE IN A HEROIN PRESCRIPTION PROGRAM AMONG INJECTION DRUG USERS
329 - THE COST OF VIROLOGIC FAILURE
330 - FACTORS ASSOCIATED WITH INTENTION TO GET TESTED FOR SYPHILIS AMONG MEN HAVING SEX WITH MEN (MSM) IN MONTREAL
331 - CHARACTERIZING DRUG INJECTING NETWORKS IN MONTREAL, CANADA
332 - WOMEN'S EXPERIENCES OF PRENATAL HIV TESTING IN ONTARIO: PROBLEMS WITH INFORMATION AND AUTONOMY
333 - STRENGTHENING NATIONAL ROUTINE AIDS SURVEILLANCE DATA: EVALUATION OF THE FIELD SURVEILLANCE OFFICER PROGRAM
334 - COLLECTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS BY LEUKAPHERESIS FOR IMMUNOLOGIC AND VIROLOGIC ANALYSES
335 - BEHAVIOURAL RISK FACTORS ASSOCIATED WITH HIV SEROPOSITIVITY AMONG CANADIAN INJECTING DRUG USERS
336 - PRIMARY HIV INFECTION STUDY: THE MONTREAL COHORT EXPERIENCE
337 - DEMOGRAPHIC CHARACTERISTICS OF WOMEN LIVING WITH HIV/AIDS IN SOUTHERN ALBERTA, 1985-2002
338 - A MONTREAL SURVEY ON HIV INFECTION AND SEXUAL BEHAVIOUR AMONG MEN HAVING SEX WITH MEN (MSM): ARGUS 2005
339 - THE SHADOW EPIDEMIC: HIGH RATES OF HEPATITIS C VIRUS INCIDENCE AMONG WOMEN AND MEN IN OTTAWA WHO INJECT DRUGS
340 - MEDICAL RECORDS AND WOMEN'S SELF-REPORT ARE BOTH UNRELIABLE FOR DETERMINING WHETHER PRENATAL HIV TESTING WAS DONE
341 - DRIED BLOOD SPOTS AS A TOOL FOR HEPATITIS C MOLECULAR EPIDEMIOLOGY
342 - SOCIAL AND RISK NETWORKS OF MALE AND FEMALE INJECTION DRUG USERS IN TORONTO: RECRUITMENT STRATEGIES
343 - RISKY INJECTION AMONGST TORONTO IDU: WITH WHOM ARE INJECTORS TAKING RISKS?
344 - RISKY INJECTION AMONGST TORONTO IDU: HOW DOES RELATIONSHIP 'CLOSENESS' AFFECT RISK
345 - FACTORS ASSOCIATED WITH NON-FATAL OVERDOSE AMONG A COHORT OF INJECTION DRUG USERS IN VANCOUVER
346 - HIT DOCTORS: CHARACTERIZING INDIVIDUALS WHO PROVIDE ASSISTANCE WITH ILLICIT DRUG INJECTIONS
347 - POTENTIAL UPTAKE AND CORRELATES OF WILLINGNESS TO USE A SUPERVISED SMOKING FACILITY FOR NON-INJECTION ILLICIT DRUG USE
348 - REQUIRING HELP INJECTING INDEPENDENTLY PREDICTS INCIDENT HIV INFECTION AMONG INJECTION DRUG USERS
349 - FACTORS ASSOCIATED WITH METHADONE MAINTENANCE THERAPY USE AMONG A COHORT OF INJECTION DRUG USERS IN VANCOUVER
350 - HIV INCIDENCE AND ASSOCIATED BEHAVIOURAL RISK FACTORS AMONG MEN HAVING SEX WITH MEN (MSM) IN THE OMEGA COHORT STUDY (OCS), MONTREAL, QUEBEC
351 - THERAPEUTIC RESPONSE DOES NOT PREDICT SUBSEQUENT MORTALITY AMONG HIV-POSITIVE ABORIGINAL PEOPLE INITIATING HAART
352 - PREVALENCE OF HIV/AIDS AMONG ABORIGINAL PEOPLE IN BRITISH COLUMBIA
353 - THE IMPACT OF HIV INFECTION ON ABSCESSES AMONG A COHORT OF INJECTION DRUG USERS
354 - RATE OF HOSPITALIZATION IN HIV+ IDUs IS NOT ASSOCIATED WITH ACCESS TO PRIMARY CARE
355 - PREVENTING INITIATION INTO INJECTION DRUG USE – PHASE 1 OF A MEDIA CAMPAIGN PROJECT